Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Resources
  • Blog

Revvityブログ

発見から治療までのイノベーションを促進

Latest

Study reveals multifaceted roles of β-arrestins in GPCR internalization, including GLP-1R.

Cell Signaling Analysis December 19, 2025 - 5 min read
Read
Small Molecule Drug Discovery

Deciphering TREM2’s role in Alzheimer’s disease.

June 6, 2024 - 4 min read
Read
Small Molecule Drug Discovery

Strategies for success: Developing safe and effective commercial cell lines.

June 6, 2024 - 2 min read
Read
Small Molecule Drug Discovery

When AlphaLISA and HTRF meet inflammatory bowel disease research needs.

June 5, 2024 - 4 min read
Read
Small Molecule Drug Discovery

How high-content is your high-content?

June 3, 2024 - 1 min read
Read
Small Molecule Drug Discovery

3 steps for successful tumor xenograft analysis.

June 3, 2024 - 3 min read
Read
Small Molecule Drug Discovery

Adopting no-wash immunoassays for higher throughput.

May 10, 2024 - 1 min read
Read
Small Molecule Drug Discovery

Advances in high-content screening: navigating the data deluge.

May 10, 2024 - 2 min read
Read
Small Molecule Drug Discovery

Novel therapeutic candidate puts the STING back into immunotherapy.

April 4, 2024 - 3 min read
Read
Small Molecule Drug Discovery

Radioligand binding assays: from opiate receptors to drug discovery mainstay.

April 3, 2024 - 2 min read
Read
Pagination
  • First page « 最初
  • Previous page Previous
  • ページ 1
  • ページ 2
  • ページ 3
  • Current page 4
line

ご質問がございましたら、
お気軽にお問い合わせください。

お問合せ
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.